Fragmin/protamine microparticles as cell carriers to enhance viability of adipose-derived stromal cells and their subsequent effect on in vivo neovascularization

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 4, 2010, Pages 1614-1622

  Nakamura, Shingo ^a   Kishimoto, Satoko ^a,b   Nakamura, Shin Ichiro ^a   Nambu, Masaki ^a   Fujita, Masanori ^a   Tanaka, Yoshihiro ^a   Mori, Yasutaka ^a   Tagawa, Masahiro ^b   Maehara, Tadaaki ^a   Ishihara, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Adipose tissue derived stromal cells (ATSCs); Angiogenesis; Angiogenic factors; Cell carrier; Fragmin protamine microparticles (F P MPs)

Indexed keywords

ADIPOSE TISSUE; ANGIOGENESIS; ANGIOGENIC FACTOR; CELL CARRIER; MICRO-PARTICLES; STROMAL CELLS;

AGGREGATES; BIOMATERIALS; ENDOTHELIAL CELLS; FIBROBLASTS; POLYSACCHARIDES; TISSUE;

CELL CULTURE;

DALTEPARIN; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR BB; PROTAMINE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROTECTION; CELL VIABILITY; ENDOTHELIUM CELL; FIBROBLAST; MALE; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; STROMA CELL;

ADIPOSE TISSUE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; DALTEPARIN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATERIALS TESTING; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTAMINES; STROMAL CELLS;

EID: 77349110733     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32506     Document Type: Article

References (30)

1. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factor: Basic principles, early results and potential hazards. Cardiovasc Res 2001;49:532-542.
2. Baffour R, Garb JL, Kaufman J, Berman J, Rhee SW, Norris MA, Friedmann P. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000;93:219-229.
3. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ishchemia: Dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992;16:181-191.
4. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 1994;93:662-670.
5. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995;21:314-324.
6. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertention 1999;33:1397-1384.
7. Kobayashi T, Hamano K, Li TS, Katoh T, Kobayashi S, Matsuzaki M, Esato K. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res 2000;89:189-195.
8. Hamano K, Li TS, Kobayashi T, Kobayashi S, Matsuzaki M, Esato K. Angiogenesis induced by the implantation of self-bone marrow cells: A new material for therapeutic angiogenesis. Cell Transplant 2000;9:439-443.
9. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-1123.
10. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, Rosenfield K, Weir L, Brogi E, Jurayj D. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Him Gene Ther 1996;7:959-988.
11. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, Sugimachi K, Sueishi K. Angiogenic gene therapy for experimental critical limb ishemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002;90:966-973.
12. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model. Circulation 2001;104:2344-2350.
13. Ikenaga S, Hamano K, Nishida M, Kobayashi T, Li TS, Kobayashi S, Matsuzaki M, Zempo N, Esato K. Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model. J Surg Res 2001;96:277-283.
14. Zuk PA, Zhu M, Ashjian P, De-Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Franser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
15. De-Ugarte DA, Morizone K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian PH, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-109.
16. Hattori H, Masuoka K, Sato M, Ishihara M, Asazuma T, Takase B, Kikuchi M, Nemoto K, Ishihara M. Bone formation using human adipose tissue-derived stromal cells and a biodegradable scaffold. J Biomed Mater Res 2006;76B:230-239.
17. Wang HJ, Pieper J, Schotel R, Van-Blitterswijk CA, Lamme EN. Stimulation of skin repair is dependent on fibroblast source and presence of extracellular matrix. Tissue Eng 2004;10:1054-1064.
18. Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T, Kaneda Y. Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 2006;13:77-81.
19. Nakamura S, Kanatani Y, Kishimoto S, Nambu M, Ohno C, Hottori H, Takase B, Tanaka Y, Yura H, Kiyosawa T, Maehara T, Ishihara M. Controlled release of FGF-2 using fragmin/protamine microparticles and effect on neovascularization. J Biomed Mater Res A 2008 Dec 2; [Epub ahead of print (DOI: 10.1002/jbm.a.32265)] .
20. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:64S-94S.
21. Wolzt M, Wetermann A, Nieszpaur-Los M, Schneider B, Fassolt A, Lechner K, Eichler H, Kyrle PA. Studies on the neutralizing of protamine on unfractionated and low molecular weight heparin (Fragmine®) at the site of activation of the coagulation system in man. Thromb Haemost 1995;73:439-443.
22. Pan M, Lezo JS, Medina A, Romero M, Hernandez E, Segura J, Melian F, Wanguemert F, Landin M, Benitez F, Amat M, Velasco F, Torres A. In-laboratory removal of femoral sheath following protamine administration in patients having intra-coronary stent implantation. Am J Cardiol 1997;80:1336-1338.
23. Masuoka K, Asazuma T, Hattori H, Yoshihara Y, Sato M, Matsumura K, Matsui T, Takase B, Nemoto K, Ishihara M. Tissue engineering of articular cartilage with autologous cultured adipose tissue-derived stromal cells using atelocollagen honeycomb-shaped scaffold with a membrane sealing in rabbits. J Biomed Mater Res 2006;79B:25-34.
24. Nambu M, Ishihara M, Nakamura S, Mizuno H, Yanagibayashi S, Kanatani Y, Hattori H, Takase B, Ishizuka T, Kishimoto S, Amano Y, Yamamoto N, Azuma R, Kiyosawa T. Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matirx. Wound Rep Reg 2007;15:505-510.
25. Nakamura S, Nambu M, Kishimoto S, Ishizuka T, Hattori H, Kanatani Y, Takase B, Aoki H, Kiyosawa T, Maehara T, Ishihara M. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex hydrogel on in vitro and in vivo vascularization. J Biomed Mater Res A 2008;85:619-627.
26. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A. Improvement of postnatal neovascularization by human adipose-tissue-derived stem cells. Circulation 2004;110:349-355.
27. Ishihara M. Biosynthesis, structure, and biological activity of basic FGF binding domains of heparan sulfate. Trend Glycosci Glycotech 1993;5:343-354.
28. Lindahl U, Lidholt K, Spillmann D, Kjellen L. More to "heparin" than anti-coagulation. Thromb Res 1994;75:1-32.
29. Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292-1298.
30. Rokstad AM, Donati I, Borgogna M, Oberholzer J, Strand BL, Espevik T, Skejak-Brak G. Cell-compatible covalently reinforced beads obtained from a chemoenzymatically engineered alginate. Biomaterials 2006;27:4726-4737.